The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
BELLWAVE-008: A phase 3 study of the efficacy and safety of nemtabrutinib in previously untreated patients (pts) with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) without TP53 aberrations.
 
Ömür Gökmen Sevindik
No Relationships to Disclose
 
Chang Chen
Employment - Merck
Travel, Accommodations, Expenses - Merck
 
Jing Yang
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Mohammed Z.H. Farooqui
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Ewa Paszkiewicz-Kozik
Consulting or Advisory Role - Takeda
Speakers' Bureau - Abbvie; Roche; Takeda
Travel, Accommodations, Expenses - Roche